Usymro
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Usymro, covering 2026-01-09 to 2026-01-09. Get the full timeline:
Most recent: EMA Authorised: Usymro (ustekinumab) — Gedeon Richter Plc.
1 regulatory and trial event tracked for Usymro, covering 2026-01-09 to 2026-01-09. Get the full timeline:
Most recent: EMA Authorised: Usymro (ustekinumab) — Gedeon Richter Plc.